Early 2023 has seen new and unprecedented financial challenges for clinical stage life sciences companies. The financing rounds of 2021 and 2022 are starting to run off, while at the same time the equity markets are either...more
The COVID-19 pandemic has resulted in significant challenges and opportunities for private equity firms and strategic buyers in the United States. Please join us for a three-part webinar series on restructuring a portfolio...more
5/15/2020
/ Acquisitions ,
Business Strategies ,
Buyers ,
CFIUS ,
Coronavirus/COVID-19 ,
Financial Distress ,
Financing ,
Mergers ,
Portfolio Companies ,
Private Equity Firms ,
Restructuring ,
Section 363 ,
Webinars